Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-EN Version v4-FR
Language English French
Date Updated 2022-07-01 2019-04-17
Drug Identification Number 02439166 02439166
Brand name NAT-QUETIAPINE NAT-QUETIAPINE
Common or Proper name Quetiapine Tablets Quetiapine Tablets
Company Name NATCO PHARMA (CANADA) INC NATCO PHARMA (CANADA) INC
Ingredients QUETIAPINE QUETIAPINE
Strength(s) 100MG 100MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100 100
ATC code N05AH N05AH
ATC description ANTIPSYCHOTICS ANTIPSYCHOTICS
Reason for shortage Requirements related to complying with good manufacturing practices. Requirements related to complying with good manufacturing practices.
Anticipated start date 2019-05-01 2019-05-01
Actual start date
Estimated end date Unknown
Actual end date 2022-06-30
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments